Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis

Bonnie W. Ramsey(Seattle Children's Hospital), Arnold L. Smith(Seattle Children's Hospital)
New England Journal of Medicine
January 7, 1999
10.1056/nejm199901073400104
Cited by 1,301

Related Papers

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
|New England Journal of Medicine|1993|455